What does PLAC I mean?
PLAC I means Pravastatin Limitation of Atherosclerosis in Coronary Arteries
This acronym/slang usually belongs to Medical & Science category.
What is the abbreviation for Pravastatin Limitation of Atherosclerosis in Coronary Arteries?
Pravastatin Limitation of Atherosclerosis in Coronary Arteries can be abbreviated as PLAC I
|
|
Most popular questions people look for before coming to this page
Q: A: |
What does PLAC I stand for? PLAC I stands for "Pravastatin Limitation of Atherosclerosis in Coronary Arteries". |
Q: A: |
How to abbreviate "Pravastatin Limitation of Atherosclerosis in Coronary Arteries"? "Pravastatin Limitation of Atherosclerosis in Coronary Arteries" can be abbreviated as PLAC I. |
Q: A: |
What is the meaning of PLAC I abbreviation? The meaning of PLAC I abbreviation is "Pravastatin Limitation of Atherosclerosis in Coronary Arteries". |
Q: A: |
What is PLAC I abbreviation? One of the definitions of PLAC I is "Pravastatin Limitation of Atherosclerosis in Coronary Arteries". |
Q: A: |
What does PLAC I mean? PLAC I as abbreviation means "Pravastatin Limitation of Atherosclerosis in Coronary Arteries". |
Q: A: |
What is shorthand of Pravastatin Limitation of Atherosclerosis in Coronary Arteries? The most common shorthand of "Pravastatin Limitation of Atherosclerosis in Coronary Arteries" is PLAC I. |
Abbreviations or Slang with similar meaning
- LIMIT AMI - Limitation of Myocardial Infarction following Thrombolysis in Acute Myocardial Infarction Study
- PDAY - Pathological Determinants of Atherosclerosis in Youth
- APRICOT - Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis
- LOGO - Limitation Of Government Obligation
- LOMT - Limitation of Medical Therapy
- LOM - Limitation of Motion
- LOB - Limitation of Benefit
- LRSW - Limitation of Relative Statistical Weights
- ASPECT - Anticoagulants in Secondary Prevention of Events in Coronary Thrombosis
- LLMC - Limitation of Liability for Maritime Claims
- PBDAY - Pathobiological Determinants of Atherosclerosis in Youth
- PDAY - Pathobiological Determinants of Atherosclerosis in Youth
- PLAC - Pravastatin Limitation of Atherosclerosis in the Coronary
- PLAC - Pravastatin Lipids and Atherosclerosis in the Carotid
- RACECAR - Restenosis and Clinical Evaluation in Coronary Arteries
- APRICOT - Antithrombotics in the Prevention of Reocclusion in Coronary
- CA - coronary arteries
- CAs - coronary arteries
- CORA - Coronary Risk Factors for Atherosclerosis in Women
- aspect - Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis